Education doesn’t stop. And neither do we.
2026 is all about: 🌎Global conversations 📍Iconic destinations 💡Real-world impact
Together, we can turn collective knowledge into clinical impact, redefining the standard of patient care.
Be part of it at https://t.co/AZGUhqNG5J.
This weekend we wrapped up the 10th MXH packed with case-based discussion and expert debate across leukemias, lymphomas, and myeloma! A decade of connection, learning, and growth. We're already looking forward to next year. Register now to save your spot, link in bio! #MXH27
Advancing Targeted Therapy in HR+/HER2- Metastatic Breast Cancer: Integrating Next-Generation Endocrine and PAM-Pathway Strategies into Practice (Spotlight CE Session) https://t.co/bbnIZgHnue
Which biomarkers actually change the treatment plan in advanced NSCLC?
@JustinGainor and @UrsWeberMD walk through the testing strategies and the latest targeted therapy and immunotherapy data in this free CME activity.
Learn more here: https://t.co/hBONMgkTCx
Oncology comes together in NYC this weekend! 🗽
📍 Future of Breast Cancer® East w/ @bcjoyceo
https://t.co/gYznG2mvtI
📍 Medical Crossfire®: Heme Malignancies w/ @szusmani@bpromd@Dr_AmerZeidan
https://t.co/uGF2cFZLg3
NYC oncologists, join us!
#IBCE26#MXH26
Immunotherapy is reshaping hepatobiliary cancer care.
In this free CME activity, @rachnatshroff and @ArndtVogel break down the safety and efficacy data, personalized treatment planning, and multidisciplinary coordination.
Start learning here: https://t.co/fYuo4GEgg4
HR+/HER2– metastatic breast cancer remains one of the most common diagnoses in oncology — and one of the fastest evolving when it comes to second-line treatment.
This free CME activity helps breaks down the evidence. Start learning now: https://t.co/OOC3Gb1CMB
3 Days. 5 Oncology Topics.
CFS® is built for community oncologists who want the latest across breast cancer, hematologic malignancies, lung cancer, and GI and GU cancers, all in one meeting.
Use code SOCIAL for 50% off HCP registration: https://t.co/Sp35pQdwpE
#CFS26#bcsm
Join @gotoPER for Adopting New Treatment Strategies in Polycythemia Vera & Essential Thrombocythemia 🩸 REGISTER👉 https://t.co/ReqPKZSnHu
HAPPENING VIRTUAL on July 8, 2026
Through real-world cases and expert discussion, leading faculty will explore:
• New clinical data and guideline updates
• Treatment selection and sequencing in PV and ET
• Emerging therapies and supportive care strategies
• Symptom monitoring and long-term disease management
Designed for hematologist-oncologists, medical oncologists, nurses, NPs/PAs, and other healthcare professionals involved in the care of patients with PV and ET.
Register today and stay current on the evolving treatment landscape.
Starting July 11, join @gotoPER for the 10th Annual Live Medical Crossfire®: Hematologic Malignancies in NYC or as a virtual attendee, co-chaired by @Dr_AmerZeidan and including 7 members of our faculty!
Register: https://t.co/ZPJzjbdOrD
@SmilowCancer@YaleHematology@YaleHemOnc
🎆 Happy 250th, America! PERcy's celebrating in star-spangled style this Fourth of July!
From all of us at PER, here's to liberty, connection, and lifelong learning.
Wishing you a safe and happy 4th! ✨
#4thOfJuly#America250#Semiquincentennial#CME#gotoPER
Need CE? PERcy has you covered. 📚
✔️ CME
✔️ NCPD
✔️ CPE
✔️ MOC
✔️ COPE
Explore 400+ educational activities across 10+ specialties, all in one place.
Visit https://t.co/CXHOLn0Bj8.
#CME#MedEd#ContinuingEducation#gotoPER